“Use of marijuana to ease back pain was common among patients at a university spine clinic in Colorado where pot has been legal for medical purposes since 2000, but most of the users did not have a prescription, according to research presented here.
Among 184 patients at a Colorado spine center, 19% said they used marijuana for pain relief, but less than half, 46%, actually had a prescription for the drug, according to study co-author Michael Finn, MD, an assistant professor of neurosurgery at the University of Colorado in Denver.
The most common way to use the drug was smoking it, 90%, followed by oral ingestion, 45%, and vaporization, 29%.
According to the users, marijuana worked. A total of 89% said it greatly or moderately relived their pain, and 81% said it worked as well as or better than narcotic painkillers.”
“One hundred percent of migraine sufferers in a self-report survey said cannabis reduced migraine pain and discomfort.”
“Cannabis treats a wide variety of conditions, but specific formulations are better for some symptoms than others, patients report in a new landmark survey by a medical cannabis industry company Care By Design.
A full 100 percent of respondents with headaches, migraines, fibromyalgia, irritable bowel syndrome (IBS), and spinal cord injury reported a decrease in pain or discomfort on medical marijuana rich in the molecule cannabidiol (CBD).”
“This report shows the antioxidant effects of a hemp seed meal protein hydrolysate (HMH) in spontaneously hypertensive rats (SHR)…
The results suggest that HMH contained antioxidant peptides that reduced the rate of lipid peroxidation in SHRs with enhanced antioxidant enzyme levels and total antioxidant capacity.”
“Cannabis sativa L., also commonly called industrial hemp seed, is historically an important source of food, fibre, dietary oil and medicine; the seed contains about 30% oil and 25% protein…
Proteins from both plant and animal sources, including those of hemp seed, have been isolated and recognized as essential sources of bioactive peptides capable of exerting various in vitro and in vivo activities, such as antioxidant, antihypertensive, antimicrobial, opioid, antithrombotic, hypocholesterolemic, appetite-reducing, mineral-binding, immunomodulatory and cytomodulatory…
HMH may serve as an important ingredient to formulate antioxidant diets with potential therapeutic effects.”
“Patients with severe psychiatric disorders actually function better in neurocognitive assessments when they have a history of marijuana use.
Patients with bipolar I disorder performed better in neurocognitive assessments when they had a history of marijuana use.”
“Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder” http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408776/
“You’ve heard about using marijuana and drugs derived from it to keep some of the side effects of toxic cancer chemotherapy in check. But what if smoking marijuana for 10 to 20 years could actually protect against certain tumors?
In a study, researchers have found that long-term pot smokers were roughly 62 percent less likely to develop head and neck cancers than people who did not smoke pot.”
“A Population-based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma” http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812803/
“Cannabidiol (CBD) is a known marijuana compound, and might just be better than antipsychotics at treating schizophrenia.
A preliminary trial has shown this form of treatment to have fewer side effects than traditional methods of treatment…
Since CBD comes from the marijuana plant, political issues are likely to compromise its availability. Extracting the compound from the plant is also expensive.
But the biggest issue scientists face is that CBD is a natural compound, and can’t be patented the way new drugs are. Pharmaceutical companies are therefore not likely to develop it.”
“Researchers at the Institute of Psychiatry at King’s College London have found further evidence of a connection between smoking marijuana and having schizophrenia. There is already research that people who smoke pot are twice as likely to have schizophrenia.
But this study has clarified the link, and the relationship doesn’t appear to be causal.
Rather, there may be an underling genetic connection.
After studying the genetic profile of more than 2,000 participants, study leader Robert Power said their research “suggests that there is likely to be an association in the other direction as well—that a predisposition to schizophrenia also increases your likelihood of cannabis use.”
Those with a genetic predisposition for schizophrenia were more likely to smoke pot and to use it in greater amounts than those without risk genes. Power said the study “highlights the complex interactions between genes and environments.””
“Cannabinoids, chemicals related to those found in cannabis could be effective in restoring neurological function by shrinking the area of the brain affected by stroke, according to a new study led by Dr. Tim England, Honorary Consultant Stroke Physician at the University of Nottingham and Royal Derby Hospital.
Stroke, a leading cause of adult disability in the UK leaves over half of all survivors dependent on others for life. Over one million people are living with the effects of stroke and it is reported that in the UK alone, over 150,000 people have a stroke every year. Finding new treatments to help survivors recover quickly has never been more important.
The authors examined 94 studies evaluating the effects of cannabinoids on 1022 mice, monkeys, and male rats. Cannabinoids can be classified into endocannabinoids that occur naturally in the body, phytocannabinoids that are obtained from plant extracts, and synthetic cannabinoids.
A meta-analysis of experimental studies conducted by the researchers at the University of Nottingham identifies the potential of all three categories of these compounds potential to reduce brain damage caused by stroke and help improve brain function after an attack.
The U.S. government sought a patent in 2001 for the naturally occuring marijuana molecule, cannabidiol, for use as a brain protector during stroke. ”
“Cannabinoids, the active ingredients in pot offer a new way to treat chronic and acute pain from sickle cell disease, ScienceDaily reports.
Currently the only treatment for the blood disease is opiods.
“Pain in SCD is described to be more intense than labor pain. The pain starts early in a patient’s life, often during infancy, and increases in severity with age.
[Cannibinoids are] effective in much lower amounts than opioids — the only currently approved treatment for this disease.”